Role of Traditional Cardiovascular Risk Factors after Initiation of Statin Therapy: A PharmLines Inception Cohort Study.
Dennis SteenhuisStijn de VosJens H J BosEelko HakPublished in: Cardiovascular therapeutics (2022)
Drug treatment for CVEs after statin initiation is increased in patients with diabetes type 2, in aged patients, males, smokers, and those with poor adherence, while there was no association with baseline cholesterol levels and blood pressure. These factors should be taken into account during the monitoring of statin therapy and may lead to changes in statin treatment or risk-related lifestyle factors.
Keyphrases
- cardiovascular disease
- cardiovascular risk factors
- low density lipoprotein
- coronary artery disease
- blood pressure
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- stem cells
- emergency department
- type diabetes
- peritoneal dialysis
- heart rate
- adipose tissue
- skeletal muscle
- bone marrow
- patient reported outcomes
- mesenchymal stem cells